Unravelling the biology of SCLC: implications for therapy JK Sabari, BH Lok, JH Laird, JT Poirier, CM Rudin Nature reviews Clinical oncology 14 (9), 549-561, 2017 | 432 | 2017 |
Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis EE Gardner, BH Lok, VE Schneeberger, P Desmeules, LA Miles, ... Cancer cell 31 (2), 286-299, 2017 | 430 | 2017 |
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer BH Lok, EE Gardner, VE Schneeberger, A Ni, P Desmeules, N Rekhtman, ... Clinical Cancer Research 23 (2), 523-535, 2017 | 299 | 2017 |
RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination BH Lok, AC Carley, B Tchang, SN Powell Oncogene 32 (30), 3552-3558, 2013 | 243 | 2013 |
New approaches to SCLC therapy: from the laboratory to the clinic JT Poirier, J George, TK Owonikoko, A Berns, E Brambilla, LA Byers, ... Journal of Thoracic Oncology 15 (4), 520-540, 2020 | 155 | 2020 |
Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement BH Lok, SN Powell Clinical cancer research 18 (23), 6400-6406, 2012 | 139 | 2012 |
Binary pan-cancer classes with distinct vulnerabilities defined by pro-or anti-cancer YAP/TEAD activity JD Pearson, K Huang, M Pacal, SR McCurdy, S Lu, A Aubry, T Yu, ... Cancer Cell 39 (8), 1115-1134. e12, 2021 | 107 | 2021 |
Target engagement imaging of PARP inhibitors in small-cell lung cancer B Carney, S Kossatz, BH Lok, V Schneeberger, KK Gangangari, ... Nature communications 9 (1), 176, 2018 | 92 | 2018 |
Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers BH Lok, G Jiang, S Gutiontov, RM Lanning, S Sridhara, EJ Sherman, ... Oral oncology 51 (10), 957-962, 2015 | 89 | 2015 |
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes BH Lok, J Setton, N Caria, J Romanyshyn, SL Wolden, MJ Zelefsky, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), 1851-1857, 2012 | 81 | 2012 |
Talazoparib is a potent radiosensitizer in small cell lung cancer cell lines and xenografts JH Laird, BH Lok, J Ma, A Bell, E de Stanchina, JT Poirier, CM Rudin Clinical Cancer Research 24 (20), 5143-5152, 2018 | 79 | 2018 |
Challenges and opportunities in primary CNS lymphoma: A systematic review MN Kerbauy, FY Moraes, BH Lok, J Ma, LN Kerbauy, DE Spratt, ... Radiotherapy and Oncology 122 (3), 352-361, 2017 | 56 | 2017 |
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer D Fan, J Ma, AC Bell, AH Groen, KS Olsen, BH Lok, JE Leeman, ... Cancer 126 (2), 444-452, 2020 | 51 | 2020 |
Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies J Ma, JH Laird, KW Chau, MR Chelius, BH Lok, J Yahalom Cancer Medicine 8 (1), 58-66, 2019 | 49 | 2019 |
Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer BH Lok, J Ma, A Foster, CA Perez, W Shi, Z Zhang, BT Li, CM Rudin, ... Advances in Radiation Oncology 2 (4), 548-554, 2017 | 47 | 2017 |
Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer A Goenka, LGT Morris, SS Rao, SL Wolden, RJ Wong, DH Kraus, N Ohri, ... International journal of cancer 133 (5), 1214-1221, 2013 | 45 | 2013 |
Impact of laparoscopic adjustable gastric banding on pregnancy, maternal weight, and neonatal health AM Carelli, CJ Ren, HA Youn, EB Friedman, AE Finger, BH Lok, ... Obesity surgery 21, 1552-1558, 2011 | 44 | 2011 |
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based … PB Romesser, R Lim, DE Spratt, J Setton, N Riaz, B Lok, S Rao, ... Oral oncology 50 (9), 802-808, 2014 | 43 | 2014 |
Intensity‐modulated radiotherapy for head and neck surgeons SI Gutiontov, EJ Shin, B Lok, NY Lee, R Cabanillas Head & neck 38 (S1), E2368-E2373, 2016 | 42 | 2016 |
Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis K Gaebe, AY Li, A Park, A Parmar, BH Lok, A Sahgal, KKW Chan, ... The Lancet Oncology 23 (7), 931-939, 2022 | 40 | 2022 |